Skip to main content
Premium Trial:

Request an Annual Quote

Krisztina Holly, Kathryn Atchison, Raymond Arner, Anne Marie Cook, Senator Max Baucus, Sharon Peterson

Premium
Entretech, a business development organization supporting high-tech companies throughout Greater Los Angeles, last week said that it has appointed two new board members: Krisztina Holly, vice provost and executive director of the University of Southern California Stevens Institute for Innovation; and Kathryn Atchison, vice provost of intellectual property and industry relations, and associate vice chancellor for research at University of California, Los Angeles. Holly and Athcison join 10 other board members.
 

 
Miller, Canfield, Paddock, and Stone, PLC, Michigan’s largest corporate law firm, last week said that it will open an office in Cambridge, Mass., to expand its work in biotechnology, life sciences, intellectual property, and venture and technology.
 
The new office will be located at One Broadway in Cambridge’s Kendall Square. Leading the office in Cambridge are Raymond Arner, former senior vice president and chief IP counsel at Biogen Idec; and Anne Marie Cook, senior vice president, business and corporate development, general counsel, and secretary of ViaCell.
 

 
The Biotechnology Industry Organization last week said that it has selected Senator Max Baucus (D-Mont.) as legislator of the year for 2006-2007.
 
Senator Baucus received the award from Sharon Peterson, executive director of Montana BioScience Alliance.
 
“Senator Baucus has been a strong proponent of the biotechnology industry and … has been a champion of the federal research and development tax credit and recently introduced the Research Competitiveness Act of 2007,” Jim Greenwood, BIO president and CEO, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more